nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—NTRK1—Imatinib—hematologic cancer	0.0847	0.161	CbGbCtD
Amitriptyline—ALB—hematologic cancer	0.0503	0.512	CbGaD
Amitriptyline—ABCB1—hematologic cancer	0.048	0.488	CbGaD
Amitriptyline—ORM1—Imatinib—hematologic cancer	0.0157	0.0299	CbGbCtD
Amitriptyline—CYP1A2—Anagrelide—hematologic cancer	0.0127	0.0242	CbGbCtD
Amitriptyline—CYP2B6—Thiotepa—hematologic cancer	0.0125	0.0237	CbGbCtD
Amitriptyline—CYP2E1—Thalidomide—hematologic cancer	0.00814	0.0155	CbGbCtD
Amitriptyline—CYP2C9—Bexarotene—hematologic cancer	0.00795	0.0151	CbGbCtD
Amitriptyline—ABCB1—Lenalidomide—hematologic cancer	0.00771	0.0147	CbGbCtD
Amitriptyline—CYP2B6—Ifosfamide—hematologic cancer	0.00707	0.0134	CbGbCtD
Amitriptyline—CYP2E1—Dacarbazine—hematologic cancer	0.007	0.0133	CbGbCtD
Amitriptyline—CYP2C8—Bortezomib—hematologic cancer	0.00698	0.0133	CbGbCtD
Amitriptyline—CYP3A5—Daunorubicin—hematologic cancer	0.00695	0.0132	CbGbCtD
Amitriptyline—CYP2D6—Lomustine—hematologic cancer	0.00676	0.0128	CbGbCtD
Amitriptyline—CYP1A2—Carmustine—hematologic cancer	0.00668	0.0127	CbGbCtD
Amitriptyline—ALB—Imatinib—hematologic cancer	0.00662	0.0126	CbGbCtD
Amitriptyline—CYP2C9—Idarubicin—hematologic cancer	0.00658	0.0125	CbGbCtD
Amitriptyline—CYP3A5—Thalidomide—hematologic cancer	0.00633	0.012	CbGbCtD
Amitriptyline—CYP2B6—Nilotinib—hematologic cancer	0.00614	0.0117	CbGbCtD
Amitriptyline—CYP3A5—Teniposide—hematologic cancer	0.00604	0.0115	CbGbCtD
Amitriptyline—CYP2D6—Idarubicin—hematologic cancer	0.00602	0.0114	CbGbCtD
Amitriptyline—CYP2C19—Bortezomib—hematologic cancer	0.00586	0.0111	CbGbCtD
Amitriptyline—CYP1A2—Methoxsalen—hematologic cancer	0.00568	0.0108	CbGbCtD
Amitriptyline—CYP3A5—Ifosfamide—hematologic cancer	0.00557	0.0106	CbGbCtD
Amitriptyline—CYP2E1—Mitoxantrone—hematologic cancer	0.00543	0.0103	CbGbCtD
Amitriptyline—CYP1A2—Bortezomib—hematologic cancer	0.00541	0.0103	CbGbCtD
Amitriptyline—CYP2C8—Ifosfamide—hematologic cancer	0.00536	0.0102	CbGbCtD
Amitriptyline—CYP3A5—Imatinib—hematologic cancer	0.00532	0.0101	CbGbCtD
Amitriptyline—CYP1A2—Daunorubicin—hematologic cancer	0.00517	0.00983	CbGbCtD
Amitriptyline—CYP2D6—Hydroxyurea—hematologic cancer	0.00512	0.00973	CbGbCtD
Amitriptyline—CYP2C19—Thalidomide—hematologic cancer	0.0051	0.0097	CbGbCtD
Amitriptyline—CYP1A2—Alitretinoin—hematologic cancer	0.00507	0.00963	CbGbCtD
Amitriptyline—CYP2C9—Bortezomib—hematologic cancer	0.00487	0.00926	CbGbCtD
Amitriptyline—CYP2C19—Teniposide—hematologic cancer	0.00487	0.00926	CbGbCtD
Amitriptyline—CYP1A2—Thalidomide—hematologic cancer	0.00471	0.00895	CbGbCtD
Amitriptyline—CYP2C8—Nilotinib—hematologic cancer	0.00465	0.00884	CbGbCtD
Amitriptyline—CYP3A4—Bexarotene—hematologic cancer	0.00462	0.00879	CbGbCtD
Amitriptyline—ABCB1—Daunorubicin—hematologic cancer	0.00452	0.0086	CbGbCtD
Amitriptyline—CYP2C19—Ifosfamide—hematologic cancer	0.00449	0.00854	CbGbCtD
Amitriptyline—CYP2D6—Bortezomib—hematologic cancer	0.00445	0.00847	CbGbCtD
Amitriptyline—ABCB1—Alitretinoin—hematologic cancer	0.00443	0.00842	CbGbCtD
Amitriptyline—ALB—Prednisone—hematologic cancer	0.00436	0.00829	CbGbCtD
Amitriptyline—CYP3A4—Lomustine—hematologic cancer	0.0043	0.00817	CbGbCtD
Amitriptyline—CYP3A4—Busulfan—hematologic cancer	0.0043	0.00817	CbGbCtD
Amitriptyline—CYP2C19—Imatinib—hematologic cancer	0.00429	0.00816	CbGbCtD
Amitriptyline—CYP3A5—Dasatinib—hematologic cancer	0.00427	0.00813	CbGbCtD
Amitriptyline—CYP2C9—Thalidomide—hematologic cancer	0.00424	0.00807	CbGbCtD
Amitriptyline—CYP2B6—Irinotecan—hematologic cancer	0.00422	0.00802	CbGbCtD
Amitriptyline—ALB—Irinotecan—hematologic cancer	0.00414	0.00786	CbGbCtD
Amitriptyline—CYP1A2—Dacarbazine—hematologic cancer	0.00405	0.0077	CbGbCtD
Amitriptyline—CYP2C9—Teniposide—hematologic cancer	0.00405	0.0077	CbGbCtD
Amitriptyline—CYP1A2—Imatinib—hematologic cancer	0.00396	0.00753	CbGbCtD
Amitriptyline—CYP3A4—Thiotepa—hematologic cancer	0.00383	0.00728	CbGbCtD
Amitriptyline—CYP2C9—Ifosfamide—hematologic cancer	0.00374	0.0071	CbGbCtD
Amitriptyline—CYP2C9—Imatinib—hematologic cancer	0.00357	0.00678	CbGbCtD
Amitriptyline—ABCB1—Imatinib—hematologic cancer	0.00346	0.00658	CbGbCtD
Amitriptyline—CYP2B6—Cisplatin—hematologic cancer	0.00344	0.00654	CbGbCtD
Amitriptyline—CYP2E1—Etoposide—hematologic cancer	0.00343	0.00651	CbGbCtD
Amitriptyline—CYP3A5—Irinotecan—hematologic cancer	0.00332	0.00632	CbGbCtD
Amitriptyline—CYP2D6—Imatinib—hematologic cancer	0.00326	0.0062	CbGbCtD
Amitriptyline—CYP2C9—Nilotinib—hematologic cancer	0.00324	0.00617	CbGbCtD
Amitriptyline—CYP1A2—Dasatinib—hematologic cancer	0.00318	0.00605	CbGbCtD
Amitriptyline—ABCB1—Nilotinib—hematologic cancer	0.00315	0.00598	CbGbCtD
Amitriptyline—ABCB1—Vinorelbine—hematologic cancer	0.00312	0.00593	CbGbCtD
Amitriptyline—CYP3A4—Methoxsalen—hematologic cancer	0.00298	0.00566	CbGbCtD
Amitriptyline—CYP2D6—Nilotinib—hematologic cancer	0.00297	0.00564	CbGbCtD
Amitriptyline—CYP2D6—Vinorelbine—hematologic cancer	0.00294	0.00559	CbGbCtD
Amitriptyline—CYP3A5—Vincristine—hematologic cancer	0.00291	0.00552	CbGbCtD
Amitriptyline—CYP3A4—Bortezomib—hematologic cancer	0.00283	0.00538	CbGbCtD
Amitriptyline—CYP2C19—Prednisone—hematologic cancer	0.00283	0.00538	CbGbCtD
Amitriptyline—CYP2E1—Dexamethasone—hematologic cancer	0.00282	0.00536	CbGbCtD
Amitriptyline—ABCB1—Dasatinib—hematologic cancer	0.00278	0.00529	CbGbCtD
Amitriptyline—CYP2B6—Dexamethasone—hematologic cancer	0.00278	0.00528	CbGbCtD
Amitriptyline—ABCB1—Mitoxantrone—hematologic cancer	0.00275	0.00522	CbGbCtD
Amitriptyline—CYP3A4—Daunorubicin—hematologic cancer	0.00271	0.00515	CbGbCtD
Amitriptyline—CYP3A5—Etoposide—hematologic cancer	0.00266	0.00506	CbGbCtD
Amitriptyline—CYP2C8—Etoposide—hematologic cancer	0.00256	0.00487	CbGbCtD
Amitriptyline—HRH4—hematopoietic system—hematologic cancer	0.0025	0.0496	CbGeAlD
Amitriptyline—ABCB1—Betamethasone—hematologic cancer	0.00245	0.00466	CbGbCtD
Amitriptyline—ABCB1—Gemcitabine—hematologic cancer	0.00243	0.00461	CbGbCtD
Amitriptyline—ABCB1—Prednisolone—hematologic cancer	0.00242	0.00459	CbGbCtD
Amitriptyline—CYP3A4—Cytarabine—hematologic cancer	0.00239	0.00454	CbGbCtD
Amitriptyline—CYP3A4—Teniposide—hematologic cancer	0.00235	0.00448	CbGbCtD
Amitriptyline—CYP2B6—Doxorubicin—hematologic cancer	0.00231	0.00438	CbGbCtD
Amitriptyline—ABCB1—Prednisone—hematologic cancer	0.00228	0.00434	CbGbCtD
Amitriptyline—CYP3A5—Dexamethasone—hematologic cancer	0.00219	0.00416	CbGbCtD
Amitriptyline—ALB—Methotrexate—hematologic cancer	0.00219	0.00416	CbGbCtD
Amitriptyline—CYP3A4—Ifosfamide—hematologic cancer	0.00217	0.00413	CbGbCtD
Amitriptyline—ABCB1—Irinotecan—hematologic cancer	0.00216	0.00411	CbGbCtD
Amitriptyline—CYP2C8—Dexamethasone—hematologic cancer	0.0021	0.004	CbGbCtD
Amitriptyline—CYP3A4—Imatinib—hematologic cancer	0.00208	0.00395	CbGbCtD
Amitriptyline—CYP1A2—Etoposide—hematologic cancer	0.00198	0.00377	CbGbCtD
Amitriptyline—CYP3A4—Ruxolitinib—hematologic cancer	0.00195	0.00372	CbGbCtD
Amitriptyline—ABCB1—Vinblastine—hematologic cancer	0.00192	0.00366	CbGbCtD
Amitriptyline—ABCB1—Vincristine—hematologic cancer	0.00189	0.00359	CbGbCtD
Amitriptyline—CYP3A4—Nilotinib—hematologic cancer	0.00189	0.00359	CbGbCtD
Amitriptyline—CYP3A4—Vinorelbine—hematologic cancer	0.00187	0.00356	CbGbCtD
Amitriptyline—CYP2C9—Cisplatin—hematologic cancer	0.00182	0.00345	CbGbCtD
Amitriptyline—CYP2D6—Vinblastine—hematologic cancer	0.00181	0.00345	CbGbCtD
Amitriptyline—NTRK2—gonad—hematologic cancer	0.00178	0.0353	CbGeAlD
Amitriptyline—CYP2C19—Dexamethasone—hematologic cancer	0.00177	0.00336	CbGbCtD
Amitriptyline—ABCB1—Cisplatin—hematologic cancer	0.00176	0.00335	CbGbCtD
Amitriptyline—ABCB1—Etoposide—hematologic cancer	0.00173	0.00329	CbGbCtD
Amitriptyline—CYP3A4—Triamcinolone—hematologic cancer	0.00171	0.00325	CbGbCtD
Amitriptyline—NTRK1—testis—hematologic cancer	0.00167	0.0332	CbGeAlD
Amitriptyline—CYP3A4—Dasatinib—hematologic cancer	0.00167	0.00317	CbGbCtD
Amitriptyline—HRH4—blood—hematologic cancer	0.00166	0.0329	CbGeAlD
Amitriptyline—CYP3A4—Mitoxantrone—hematologic cancer	0.00165	0.00313	CbGbCtD
Amitriptyline—HRH4—bone marrow—hematologic cancer	0.0016	0.0318	CbGeAlD
Amitriptyline—NTRK2—bone marrow—hematologic cancer	0.0015	0.0298	CbGeAlD
Amitriptyline—CYP2C9—Dexamethasone—hematologic cancer	0.00147	0.00279	CbGbCtD
Amitriptyline—CYP3A4—Betamethasone—hematologic cancer	0.00147	0.00279	CbGbCtD
Amitriptyline—CYP3A4—Prednisolone—hematologic cancer	0.00145	0.00275	CbGbCtD
Amitriptyline—ABCB1—Dexamethasone—hematologic cancer	0.00142	0.00271	CbGbCtD
Amitriptyline—CYP3A4—Prednisone—hematologic cancer	0.00137	0.0026	CbGbCtD
Amitriptyline—NTRK2—lung—hematologic cancer	0.00136	0.027	CbGeAlD
Amitriptyline—CYP2D6—Dexamethasone—hematologic cancer	0.00134	0.00255	CbGbCtD
Amitriptyline—CYP3A4—Irinotecan—hematologic cancer	0.0013	0.00246	CbGbCtD
Amitriptyline—NTRK2—testis—hematologic cancer	0.00128	0.0254	CbGeAlD
Amitriptyline—KCNQ2—gonad—hematologic cancer	0.00124	0.0246	CbGeAlD
Amitriptyline—ABCB1—Doxorubicin—hematologic cancer	0.00118	0.00225	CbGbCtD
Amitriptyline—CYP3A4—Vinblastine—hematologic cancer	0.00115	0.00219	CbGbCtD
Amitriptyline—ABCB1—Methotrexate—hematologic cancer	0.00114	0.00218	CbGbCtD
Amitriptyline—CYP3A4—Vincristine—hematologic cancer	0.00113	0.00215	CbGbCtD
Amitriptyline—CYP2D6—Doxorubicin—hematologic cancer	0.00111	0.00212	CbGbCtD
Amitriptyline—HRH2—hematopoietic system—hematologic cancer	0.00105	0.0208	CbGeAlD
Amitriptyline—CYP3A4—Etoposide—hematologic cancer	0.00104	0.00197	CbGbCtD
Amitriptyline—KCNQ3—lung—hematologic cancer	0.00103	0.0204	CbGeAlD
Amitriptyline—NTRK2—lymph node—hematologic cancer	0.000929	0.0184	CbGeAlD
Amitriptyline—KCNQ2—testis—hematologic cancer	0.000894	0.0177	CbGeAlD
Amitriptyline—CYP3A4—Dexamethasone—hematologic cancer	0.000853	0.00162	CbGbCtD
Amitriptyline—KCND2—testis—hematologic cancer	0.000846	0.0168	CbGeAlD
Amitriptyline—KCND3—lung—hematologic cancer	0.000782	0.0155	CbGeAlD
Amitriptyline—OPRM1—hematopoietic system—hematologic cancer	0.000756	0.015	CbGeAlD
Amitriptyline—ORM1—hematopoietic system—hematologic cancer	0.000738	0.0147	CbGeAlD
Amitriptyline—KCND3—testis—hematologic cancer	0.000738	0.0146	CbGeAlD
Amitriptyline—CYP3A4—Doxorubicin—hematologic cancer	0.000708	0.00135	CbGbCtD
Amitriptyline—CHRM4—testis—hematologic cancer	0.000703	0.014	CbGeAlD
Amitriptyline—HRH2—blood—hematologic cancer	0.000695	0.0138	CbGeAlD
Amitriptyline—SLC6A4—hematopoietic system—hematologic cancer	0.000629	0.0125	CbGeAlD
Amitriptyline—HRH2—lung—hematologic cancer	0.00061	0.0121	CbGeAlD
Amitriptyline—HTR1A—hematopoietic system—hematologic cancer	0.000558	0.0111	CbGeAlD
Amitriptyline—KCND3—lymph node—hematologic cancer	0.000535	0.0106	CbGeAlD
Amitriptyline—HTR7—hematopoietic system—hematologic cancer	0.000534	0.0106	CbGeAlD
Amitriptyline—CYP2C19—hematopoietic system—hematologic cancer	0.000521	0.0103	CbGeAlD
Amitriptyline—ADRA1A—hematopoietic system—hematologic cancer	0.000515	0.0102	CbGeAlD
Amitriptyline—OPRM1—blood—hematologic cancer	0.000501	0.00994	CbGeAlD
Amitriptyline—ORM1—blood—hematologic cancer	0.000489	0.00971	CbGeAlD
Amitriptyline—ORM1—bone marrow—hematologic cancer	0.000473	0.00939	CbGeAlD
Amitriptyline—CYP2C8—hematopoietic system—hematologic cancer	0.000455	0.00903	CbGeAlD
Amitriptyline—ORM1—lung—hematologic cancer	0.000429	0.00851	CbGeAlD
Amitriptyline—CYP1A2—hematopoietic system—hematologic cancer	0.000426	0.00845	CbGeAlD
Amitriptyline—SLC6A2—gonad—hematologic cancer	0.000421	0.00836	CbGeAlD
Amitriptyline—HRH2—lymph node—hematologic cancer	0.000417	0.00828	CbGeAlD
Amitriptyline—SLC6A4—blood—hematologic cancer	0.000417	0.00827	CbGeAlD
Amitriptyline—OPRM1—testis—hematologic cancer	0.000414	0.00823	CbGeAlD
Amitriptyline—SIGMAR1—blood—hematologic cancer	0.000414	0.00821	CbGeAlD
Amitriptyline—CYP3A5—hematopoietic system—hematologic cancer	0.00041	0.00815	CbGeAlD
Amitriptyline—CYP2B6—hematopoietic system—hematologic cancer	0.000408	0.0081	CbGeAlD
Amitriptyline—HTR7—gonad—hematologic cancer	0.000406	0.00805	CbGeAlD
Amitriptyline—CYP2C9—hematopoietic system—hematologic cancer	0.000404	0.00802	CbGeAlD
Amitriptyline—SIGMAR1—bone marrow—hematologic cancer	0.0004	0.00795	CbGeAlD
Amitriptyline—HRH1—hematopoietic system—hematologic cancer	0.000398	0.00791	CbGeAlD
Amitriptyline—ADRA2A—hematopoietic system—hematologic cancer	0.000391	0.00777	CbGeAlD
Amitriptyline—CYP2E1—hematopoietic system—hematologic cancer	0.000383	0.0076	CbGeAlD
Amitriptyline—SLC6A4—lung—hematologic cancer	0.000365	0.00725	CbGeAlD
Amitriptyline—CHRM1—lung—hematologic cancer	0.000364	0.00722	CbGeAlD
Amitriptyline—SIGMAR1—lung—hematologic cancer	0.000363	0.0072	CbGeAlD
Amitriptyline—ALB—testis—hematologic cancer	0.000355	0.00704	CbGeAlD
Amitriptyline—HTR7—blood—hematologic cancer	0.000354	0.00702	CbGeAlD
Amitriptyline—CYP2C19—blood—hematologic cancer	0.000345	0.00685	CbGeAlD
Amitriptyline—SIGMAR1—testis—hematologic cancer	0.000342	0.00679	CbGeAlD
Amitriptyline—ADRA1A—blood—hematologic cancer	0.000341	0.00677	CbGeAlD
Amitriptyline—HTR2A—hematopoietic system—hematologic cancer	0.000333	0.00661	CbGeAlD
Amitriptyline—SLC6A2—lung—hematologic cancer	0.000322	0.00638	CbGeAlD
Amitriptyline—CYP2B6—gonad—hematologic cancer	0.00031	0.00616	CbGeAlD
Amitriptyline—HTR7—lung—hematologic cancer	0.00031	0.00615	CbGeAlD
Amitriptyline—CYP3A4—hematopoietic system—hematologic cancer	0.000308	0.00612	CbGeAlD
Amitriptyline—CHRM3—testis—hematologic cancer	0.000307	0.0061	CbGeAlD
Amitriptyline—SLC6A2—testis—hematologic cancer	0.000303	0.00602	CbGeAlD
Amitriptyline—CYP2D6—hematopoietic system—hematologic cancer	0.000303	0.00602	CbGeAlD
Amitriptyline—CYP2C8—blood—hematologic cancer	0.000301	0.00598	CbGeAlD
Amitriptyline—ADRA2A—gonad—hematologic cancer	0.000298	0.00591	CbGeAlD
Amitriptyline—ORM1—lymph node—hematologic cancer	0.000293	0.00582	CbGeAlD
Amitriptyline—DRD2—lung—hematologic cancer	0.000293	0.00582	CbGeAlD
Amitriptyline—HTR7—testis—hematologic cancer	0.000292	0.00581	CbGeAlD
Amitriptyline—CYP1A2—blood—hematologic cancer	0.000282	0.0056	CbGeAlD
Amitriptyline—DRD2—testis—hematologic cancer	0.000276	0.00549	CbGeAlD
Amitriptyline—CYP3A5—blood—hematologic cancer	0.000272	0.0054	CbGeAlD
Amitriptyline—CYP2B6—blood—hematologic cancer	0.00027	0.00537	CbGeAlD
Amitriptyline—CYP2C9—blood—hematologic cancer	0.000268	0.00531	CbGeAlD
Amitriptyline—ADRA2A—blood—hematologic cancer	0.000259	0.00515	CbGeAlD
Amitriptyline—ALB—lymph node—hematologic cancer	0.000257	0.0051	CbGeAlD
Amitriptyline—CYP2E1—blood—hematologic cancer	0.000254	0.00504	CbGeAlD
Amitriptyline—HTR2A—gonad—hematologic cancer	0.000253	0.00502	CbGeAlD
Amitriptyline—CYP2C8—testis—hematologic cancer	0.000249	0.00495	CbGeAlD
Amitriptyline—SIGMAR1—lymph node—hematologic cancer	0.000248	0.00493	CbGeAlD
Amitriptyline—CYP1A2—lung—hematologic cancer	0.000247	0.00491	CbGeAlD
Amitriptyline—CYP3A5—lung—hematologic cancer	0.000238	0.00473	CbGeAlD
Amitriptyline—CYP2B6—lung—hematologic cancer	0.000237	0.0047	CbGeAlD
Amitriptyline—HRH1—lung—hematologic cancer	0.000231	0.00459	CbGeAlD
Amitriptyline—ADRA2A—lung—hematologic cancer	0.000227	0.00451	CbGeAlD
Amitriptyline—CYP2B6—testis—hematologic cancer	0.000224	0.00444	CbGeAlD
Amitriptyline—CYP2E1—lung—hematologic cancer	0.000222	0.00441	CbGeAlD
Amitriptyline—HTR2A—blood—hematologic cancer	0.00022	0.00438	CbGeAlD
Amitriptyline—SLC6A2—lymph node—hematologic cancer	0.00022	0.00437	CbGeAlD
Amitriptyline—HRH1—testis—hematologic cancer	0.000218	0.00433	CbGeAlD
Amitriptyline—ABCB1—hematopoietic system—hematologic cancer	0.000218	0.00433	CbGeAlD
Amitriptyline—ADRA2A—testis—hematologic cancer	0.000214	0.00426	CbGeAlD
Amitriptyline—CYP2E1—testis—hematologic cancer	0.00021	0.00417	CbGeAlD
Amitriptyline—CYP3A4—blood—hematologic cancer	0.000204	0.00405	CbGeAlD
Amitriptyline—CYP2D6—blood—hematologic cancer	0.000201	0.00399	CbGeAlD
Amitriptyline—HTR2A—lung—hematologic cancer	0.000193	0.00384	CbGeAlD
Amitriptyline—HTR2A—testis—hematologic cancer	0.000182	0.00362	CbGeAlD
Amitriptyline—CYP2D6—testis—hematologic cancer	0.000166	0.0033	CbGeAlD
Amitriptyline—ABCB1—gonad—hematologic cancer	0.000166	0.00329	CbGeAlD
Amitriptyline—HRH1—lymph node—hematologic cancer	0.000158	0.00314	CbGeAlD
Amitriptyline—ADRA2A—lymph node—hematologic cancer	0.000155	0.00309	CbGeAlD
Amitriptyline—ABCB1—blood—hematologic cancer	0.000144	0.00287	CbGeAlD
Amitriptyline—ABCB1—bone marrow—hematologic cancer	0.00014	0.00278	CbGeAlD
Amitriptyline—Thiothixene—SLC22A1—hematologic cancer	0.000139	0.147	CrCbGaD
Amitriptyline—ABCB1—lung—hematologic cancer	0.000127	0.00251	CbGeAlD
Amitriptyline—ABCB1—testis—hematologic cancer	0.000119	0.00237	CbGeAlD
Amitriptyline—Clomipramine—GSTP1—hematologic cancer	0.000119	0.126	CrCbGaD
Amitriptyline—Diphenhydramine—SLC22A1—hematologic cancer	9.92e-05	0.105	CrCbGaD
Amitriptyline—Desipramine—SLC22A1—hematologic cancer	8.83e-05	0.0936	CrCbGaD
Amitriptyline—ABCB1—lymph node—hematologic cancer	8.66e-05	0.00172	CbGeAlD
Amitriptyline—Imipramine—SLC22A1—hematologic cancer	7.49e-05	0.0794	CrCbGaD
Amitriptyline—Epinastine—ABCB1—hematologic cancer	6.03e-05	0.0639	CrCbGaD
Amitriptyline—Oxcarbazepine—ALB—hematologic cancer	5.82e-05	0.0617	CrCbGaD
Amitriptyline—Thiothixene—ALB—hematologic cancer	4.23e-05	0.0448	CrCbGaD
Amitriptyline—Malaise—Prednisone—hematologic cancer	3.4e-05	0.000176	CcSEcCtD
Amitriptyline—Body temperature increased—Etoposide—hematologic cancer	3.39e-05	0.000176	CcSEcCtD
Amitriptyline—Hepatitis—Epirubicin—hematologic cancer	3.39e-05	0.000176	CcSEcCtD
Amitriptyline—Syncope—Prednisone—hematologic cancer	3.38e-05	0.000175	CcSEcCtD
Amitriptyline—Tinnitus—Methotrexate—hematologic cancer	3.37e-05	0.000175	CcSEcCtD
Amitriptyline—Hypoaesthesia—Epirubicin—hematologic cancer	3.37e-05	0.000175	CcSEcCtD
Amitriptyline—Vomiting—Vincristine—hematologic cancer	3.37e-05	0.000175	CcSEcCtD
Amitriptyline—Anorexia—Betamethasone—hematologic cancer	3.37e-05	0.000175	CcSEcCtD
Amitriptyline—Anorexia—Dexamethasone—hematologic cancer	3.37e-05	0.000175	CcSEcCtD
Amitriptyline—Urticaria—Prednisolone—hematologic cancer	3.36e-05	0.000174	CcSEcCtD
Amitriptyline—Asthenia—Cisplatin—hematologic cancer	3.36e-05	0.000174	CcSEcCtD
Amitriptyline—Fatigue—Triamcinolone—hematologic cancer	3.36e-05	0.000174	CcSEcCtD
Amitriptyline—Clomipramine—ALB—hematologic cancer	3.34e-05	0.0354	CrCbGaD
Amitriptyline—Rash—Vincristine—hematologic cancer	3.34e-05	0.000173	CcSEcCtD
Amitriptyline—Dermatitis—Vincristine—hematologic cancer	3.34e-05	0.000173	CcSEcCtD
Amitriptyline—Headache—Vincristine—hematologic cancer	3.32e-05	0.000172	CcSEcCtD
Amitriptyline—Loss of consciousness—Prednisone—hematologic cancer	3.31e-05	0.000172	CcSEcCtD
Amitriptyline—Hypotension—Dexamethasone—hematologic cancer	3.3e-05	0.000171	CcSEcCtD
Amitriptyline—Hypotension—Betamethasone—hematologic cancer	3.3e-05	0.000171	CcSEcCtD
Amitriptyline—Nausea—Carmustine—hematologic cancer	3.3e-05	0.000171	CcSEcCtD
Amitriptyline—Vomiting—Mitoxantrone—hematologic cancer	3.28e-05	0.00017	CcSEcCtD
Amitriptyline—Vomiting—Irinotecan—hematologic cancer	3.28e-05	0.00017	CcSEcCtD
Amitriptyline—Nortriptyline—ALB—hematologic cancer	3.27e-05	0.0346	CrCbGaD
Amitriptyline—Nausea—Alitretinoin—hematologic cancer	3.27e-05	0.000169	CcSEcCtD
Amitriptyline—Convulsion—Prednisone—hematologic cancer	3.27e-05	0.000169	CcSEcCtD
Amitriptyline—Agranulocytosis—Doxorubicin—hematologic cancer	3.26e-05	0.000169	CcSEcCtD
Amitriptyline—Hypertension—Prednisone—hematologic cancer	3.25e-05	0.000169	CcSEcCtD
Amitriptyline—Rash—Mitoxantrone—hematologic cancer	3.25e-05	0.000169	CcSEcCtD
Amitriptyline—Rash—Irinotecan—hematologic cancer	3.25e-05	0.000169	CcSEcCtD
Amitriptyline—Dermatitis—Irinotecan—hematologic cancer	3.25e-05	0.000169	CcSEcCtD
Amitriptyline—Dermatitis—Mitoxantrone—hematologic cancer	3.25e-05	0.000169	CcSEcCtD
Amitriptyline—Headache—Irinotecan—hematologic cancer	3.23e-05	0.000168	CcSEcCtD
Amitriptyline—Headache—Mitoxantrone—hematologic cancer	3.23e-05	0.000168	CcSEcCtD
Amitriptyline—Nausea—Ifosfamide—hematologic cancer	3.23e-05	0.000167	CcSEcCtD
Amitriptyline—Feeling abnormal—Triamcinolone—hematologic cancer	3.21e-05	0.000166	CcSEcCtD
Amitriptyline—Diarrhoea—Cisplatin—hematologic cancer	3.21e-05	0.000166	CcSEcCtD
Amitriptyline—Anxiety—Prednisone—hematologic cancer	3.2e-05	0.000166	CcSEcCtD
Amitriptyline—Alopecia—Methotrexate—hematologic cancer	3.2e-05	0.000166	CcSEcCtD
Amitriptyline—Vomiting—Gemcitabine—hematologic cancer	3.2e-05	0.000166	CcSEcCtD
Amitriptyline—Insomnia—Betamethasone—hematologic cancer	3.2e-05	0.000166	CcSEcCtD
Amitriptyline—Insomnia—Dexamethasone—hematologic cancer	3.2e-05	0.000166	CcSEcCtD
Amitriptyline—Clomipramine—ABCB1—hematologic cancer	3.19e-05	0.0338	CrCbGaD
Amitriptyline—Chlorprothixene—ABCB1—hematologic cancer	3.18e-05	0.0337	CrCbGaD
Amitriptyline—Paraesthesia—Betamethasone—hematologic cancer	3.17e-05	0.000164	CcSEcCtD
Amitriptyline—Paraesthesia—Dexamethasone—hematologic cancer	3.17e-05	0.000164	CcSEcCtD
Amitriptyline—Discomfort—Prednisone—hematologic cancer	3.17e-05	0.000164	CcSEcCtD
Amitriptyline—Rash—Gemcitabine—hematologic cancer	3.17e-05	0.000164	CcSEcCtD
Amitriptyline—Dermatitis—Gemcitabine—hematologic cancer	3.17e-05	0.000164	CcSEcCtD
Amitriptyline—Tinnitus—Epirubicin—hematologic cancer	3.16e-05	0.000164	CcSEcCtD
Amitriptyline—Headache—Gemcitabine—hematologic cancer	3.15e-05	0.000163	CcSEcCtD
Amitriptyline—Nausea—Vincristine—hematologic cancer	3.15e-05	0.000163	CcSEcCtD
Amitriptyline—Hepatitis—Doxorubicin—hematologic cancer	3.13e-05	0.000162	CcSEcCtD
Amitriptyline—Hypoaesthesia—Doxorubicin—hematologic cancer	3.12e-05	0.000162	CcSEcCtD
Amitriptyline—Dyspepsia—Dexamethasone—hematologic cancer	3.11e-05	0.000161	CcSEcCtD
Amitriptyline—Dyspepsia—Betamethasone—hematologic cancer	3.11e-05	0.000161	CcSEcCtD
Amitriptyline—Urticaria—Triamcinolone—hematologic cancer	3.09e-05	0.00016	CcSEcCtD
Amitriptyline—Dysgeusia—Methotrexate—hematologic cancer	3.09e-05	0.00016	CcSEcCtD
Amitriptyline—Asthenia—Etoposide—hematologic cancer	3.08e-05	0.00016	CcSEcCtD
Amitriptyline—Body temperature increased—Triamcinolone—hematologic cancer	3.08e-05	0.00016	CcSEcCtD
Amitriptyline—Oedema—Prednisone—hematologic cancer	3.08e-05	0.00016	CcSEcCtD
Amitriptyline—Decreased appetite—Dexamethasone—hematologic cancer	3.07e-05	0.000159	CcSEcCtD
Amitriptyline—Decreased appetite—Betamethasone—hematologic cancer	3.07e-05	0.000159	CcSEcCtD
Amitriptyline—Nausea—Mitoxantrone—hematologic cancer	3.07e-05	0.000159	CcSEcCtD
Amitriptyline—Nausea—Irinotecan—hematologic cancer	3.07e-05	0.000159	CcSEcCtD
Amitriptyline—Fatigue—Dexamethasone—hematologic cancer	3.05e-05	0.000158	CcSEcCtD
Amitriptyline—Fatigue—Betamethasone—hematologic cancer	3.05e-05	0.000158	CcSEcCtD
Amitriptyline—Pruritus—Etoposide—hematologic cancer	3.04e-05	0.000157	CcSEcCtD
Amitriptyline—Shock—Prednisone—hematologic cancer	3.03e-05	0.000157	CcSEcCtD
Amitriptyline—Arrhythmia—Epirubicin—hematologic cancer	3.03e-05	0.000157	CcSEcCtD
Amitriptyline—Tachycardia—Prednisone—hematologic cancer	3e-05	0.000156	CcSEcCtD
Amitriptyline—Alopecia—Epirubicin—hematologic cancer	2.99e-05	0.000155	CcSEcCtD
Amitriptyline—Nausea—Gemcitabine—hematologic cancer	2.99e-05	0.000155	CcSEcCtD
Amitriptyline—Vomiting—Cisplatin—hematologic cancer	2.98e-05	0.000154	CcSEcCtD
Amitriptyline—Hyperhidrosis—Prednisone—hematologic cancer	2.97e-05	0.000154	CcSEcCtD
Amitriptyline—Vision blurred—Methotrexate—hematologic cancer	2.97e-05	0.000154	CcSEcCtD
Amitriptyline—Rash—Cisplatin—hematologic cancer	2.95e-05	0.000153	CcSEcCtD
Amitriptyline—Dermatitis—Cisplatin—hematologic cancer	2.95e-05	0.000153	CcSEcCtD
Amitriptyline—Diarrhoea—Etoposide—hematologic cancer	2.94e-05	0.000152	CcSEcCtD
Amitriptyline—Trimipramine—ABCB1—hematologic cancer	2.94e-05	0.0311	CrCbGaD
Amitriptyline—Anorexia—Prednisone—hematologic cancer	2.93e-05	0.000152	CcSEcCtD
Amitriptyline—Ill-defined disorder—Methotrexate—hematologic cancer	2.92e-05	0.000152	CcSEcCtD
Amitriptyline—Tinnitus—Doxorubicin—hematologic cancer	2.92e-05	0.000151	CcSEcCtD
Amitriptyline—Feeling abnormal—Betamethasone—hematologic cancer	2.91e-05	0.000151	CcSEcCtD
Amitriptyline—Feeling abnormal—Dexamethasone—hematologic cancer	2.91e-05	0.000151	CcSEcCtD
Amitriptyline—Dysgeusia—Epirubicin—hematologic cancer	2.89e-05	0.00015	CcSEcCtD
Amitriptyline—Malaise—Methotrexate—hematologic cancer	2.84e-05	0.000147	CcSEcCtD
Amitriptyline—Dizziness—Etoposide—hematologic cancer	2.84e-05	0.000147	CcSEcCtD
Amitriptyline—Promethazine—ABCB1—hematologic cancer	2.83e-05	0.03	CrCbGaD
Amitriptyline—Leukopenia—Methotrexate—hematologic cancer	2.82e-05	0.000146	CcSEcCtD
Amitriptyline—Urticaria—Dexamethasone—hematologic cancer	2.81e-05	0.000145	CcSEcCtD
Amitriptyline—Urticaria—Betamethasone—hematologic cancer	2.81e-05	0.000145	CcSEcCtD
Amitriptyline—Dizziness—Prednisolone—hematologic cancer	2.8e-05	0.000145	CcSEcCtD
Amitriptyline—Arrhythmia—Doxorubicin—hematologic cancer	2.8e-05	0.000145	CcSEcCtD
Amitriptyline—Doxepin—ABCB1—hematologic cancer	2.8e-05	0.0297	CrCbGaD
Amitriptyline—Asthenia—Triamcinolone—hematologic cancer	2.79e-05	0.000145	CcSEcCtD
Amitriptyline—Body temperature increased—Betamethasone—hematologic cancer	2.79e-05	0.000145	CcSEcCtD
Amitriptyline—Body temperature increased—Dexamethasone—hematologic cancer	2.79e-05	0.000145	CcSEcCtD
Amitriptyline—Nausea—Cisplatin—hematologic cancer	2.78e-05	0.000144	CcSEcCtD
Amitriptyline—Insomnia—Prednisone—hematologic cancer	2.78e-05	0.000144	CcSEcCtD
Amitriptyline—Vision blurred—Epirubicin—hematologic cancer	2.78e-05	0.000144	CcSEcCtD
Amitriptyline—Alopecia—Doxorubicin—hematologic cancer	2.77e-05	0.000144	CcSEcCtD
Amitriptyline—Paraesthesia—Prednisone—hematologic cancer	2.76e-05	0.000143	CcSEcCtD
Amitriptyline—Pruritus—Triamcinolone—hematologic cancer	2.75e-05	0.000143	CcSEcCtD
Amitriptyline—Ill-defined disorder—Epirubicin—hematologic cancer	2.74e-05	0.000142	CcSEcCtD
Amitriptyline—Convulsion—Methotrexate—hematologic cancer	2.73e-05	0.000142	CcSEcCtD
Amitriptyline—Vomiting—Etoposide—hematologic cancer	2.73e-05	0.000141	CcSEcCtD
Amitriptyline—Agitation—Epirubicin—hematologic cancer	2.71e-05	0.00014	CcSEcCtD
Amitriptyline—Dyspepsia—Prednisone—hematologic cancer	2.71e-05	0.00014	CcSEcCtD
Amitriptyline—Rash—Etoposide—hematologic cancer	2.71e-05	0.00014	CcSEcCtD
Amitriptyline—Dermatitis—Etoposide—hematologic cancer	2.7e-05	0.00014	CcSEcCtD
Amitriptyline—Headache—Etoposide—hematologic cancer	2.69e-05	0.000139	CcSEcCtD
Amitriptyline—Decreased appetite—Prednisone—hematologic cancer	2.67e-05	0.000139	CcSEcCtD
Amitriptyline—Dysgeusia—Doxorubicin—hematologic cancer	2.67e-05	0.000138	CcSEcCtD
Amitriptyline—Rash—Prednisolone—hematologic cancer	2.67e-05	0.000138	CcSEcCtD
Amitriptyline—Dermatitis—Prednisolone—hematologic cancer	2.67e-05	0.000138	CcSEcCtD
Amitriptyline—Malaise—Epirubicin—hematologic cancer	2.66e-05	0.000138	CcSEcCtD
Amitriptyline—Fatigue—Prednisone—hematologic cancer	2.65e-05	0.000138	CcSEcCtD
Amitriptyline—Headache—Prednisolone—hematologic cancer	2.65e-05	0.000138	CcSEcCtD
Amitriptyline—Discomfort—Methotrexate—hematologic cancer	2.65e-05	0.000137	CcSEcCtD
Amitriptyline—Syncope—Epirubicin—hematologic cancer	2.64e-05	0.000137	CcSEcCtD
Amitriptyline—Leukopenia—Epirubicin—hematologic cancer	2.64e-05	0.000137	CcSEcCtD
Amitriptyline—Constipation—Prednisone—hematologic cancer	2.63e-05	0.000136	CcSEcCtD
Amitriptyline—Palpitations—Epirubicin—hematologic cancer	2.61e-05	0.000135	CcSEcCtD
Amitriptyline—Confusional state—Methotrexate—hematologic cancer	2.59e-05	0.000134	CcSEcCtD
Amitriptyline—Loss of consciousness—Epirubicin—hematologic cancer	2.59e-05	0.000134	CcSEcCtD
Amitriptyline—Dizziness—Triamcinolone—hematologic cancer	2.57e-05	0.000133	CcSEcCtD
Amitriptyline—Vision blurred—Doxorubicin—hematologic cancer	2.57e-05	0.000133	CcSEcCtD
Amitriptyline—Desipramine—ABCB1—hematologic cancer	2.57e-05	0.0272	CrCbGaD
Amitriptyline—Convulsion—Epirubicin—hematologic cancer	2.55e-05	0.000132	CcSEcCtD
Amitriptyline—Nausea—Etoposide—hematologic cancer	2.55e-05	0.000132	CcSEcCtD
Amitriptyline—Hypertension—Epirubicin—hematologic cancer	2.55e-05	0.000132	CcSEcCtD
Amitriptyline—Feeling abnormal—Prednisone—hematologic cancer	2.54e-05	0.000131	CcSEcCtD
Amitriptyline—Asthenia—Dexamethasone—hematologic cancer	2.53e-05	0.000131	CcSEcCtD
Amitriptyline—Asthenia—Betamethasone—hematologic cancer	2.53e-05	0.000131	CcSEcCtD
Amitriptyline—Ill-defined disorder—Doxorubicin—hematologic cancer	2.53e-05	0.000131	CcSEcCtD
Amitriptyline—Thrombocytopenia—Methotrexate—hematologic cancer	2.52e-05	0.000131	CcSEcCtD
Amitriptyline—Nausea—Prednisolone—hematologic cancer	2.51e-05	0.00013	CcSEcCtD
Amitriptyline—Agitation—Doxorubicin—hematologic cancer	2.51e-05	0.00013	CcSEcCtD
Amitriptyline—Anxiety—Epirubicin—hematologic cancer	2.5e-05	0.00013	CcSEcCtD
Amitriptyline—Pruritus—Dexamethasone—hematologic cancer	2.5e-05	0.00013	CcSEcCtD
Amitriptyline—Pruritus—Betamethasone—hematologic cancer	2.5e-05	0.00013	CcSEcCtD
Amitriptyline—Hyperhidrosis—Methotrexate—hematologic cancer	2.49e-05	0.000129	CcSEcCtD
Amitriptyline—Discomfort—Epirubicin—hematologic cancer	2.48e-05	0.000129	CcSEcCtD
Amitriptyline—Vomiting—Triamcinolone—hematologic cancer	2.48e-05	0.000128	CcSEcCtD
Amitriptyline—Malaise—Doxorubicin—hematologic cancer	2.46e-05	0.000128	CcSEcCtD
Amitriptyline—Rash—Triamcinolone—hematologic cancer	2.45e-05	0.000127	CcSEcCtD
Amitriptyline—Dry mouth—Epirubicin—hematologic cancer	2.45e-05	0.000127	CcSEcCtD
Amitriptyline—Dermatitis—Triamcinolone—hematologic cancer	2.45e-05	0.000127	CcSEcCtD
Amitriptyline—Anorexia—Methotrexate—hematologic cancer	2.45e-05	0.000127	CcSEcCtD
Amitriptyline—Syncope—Doxorubicin—hematologic cancer	2.45e-05	0.000127	CcSEcCtD
Amitriptyline—Urticaria—Prednisone—hematologic cancer	2.44e-05	0.000127	CcSEcCtD
Amitriptyline—Leukopenia—Doxorubicin—hematologic cancer	2.44e-05	0.000127	CcSEcCtD
Amitriptyline—Headache—Triamcinolone—hematologic cancer	2.44e-05	0.000126	CcSEcCtD
Amitriptyline—Body temperature increased—Prednisone—hematologic cancer	2.43e-05	0.000126	CcSEcCtD
Amitriptyline—Confusional state—Epirubicin—hematologic cancer	2.43e-05	0.000126	CcSEcCtD
Amitriptyline—Diarrhoea—Dexamethasone—hematologic cancer	2.42e-05	0.000125	CcSEcCtD
Amitriptyline—Diarrhoea—Betamethasone—hematologic cancer	2.42e-05	0.000125	CcSEcCtD
Amitriptyline—Palpitations—Doxorubicin—hematologic cancer	2.41e-05	0.000125	CcSEcCtD
Amitriptyline—Oedema—Epirubicin—hematologic cancer	2.41e-05	0.000125	CcSEcCtD
Amitriptyline—Hypotension—Methotrexate—hematologic cancer	2.4e-05	0.000125	CcSEcCtD
Amitriptyline—Loss of consciousness—Doxorubicin—hematologic cancer	2.4e-05	0.000124	CcSEcCtD
Amitriptyline—Shock—Epirubicin—hematologic cancer	2.37e-05	0.000123	CcSEcCtD
Amitriptyline—Convulsion—Doxorubicin—hematologic cancer	2.36e-05	0.000123	CcSEcCtD
Amitriptyline—Thrombocytopenia—Epirubicin—hematologic cancer	2.36e-05	0.000122	CcSEcCtD
Amitriptyline—Hypertension—Doxorubicin—hematologic cancer	2.36e-05	0.000122	CcSEcCtD
Amitriptyline—Tachycardia—Epirubicin—hematologic cancer	2.35e-05	0.000122	CcSEcCtD
Amitriptyline—Dizziness—Betamethasone—hematologic cancer	2.34e-05	0.000121	CcSEcCtD
Amitriptyline—Dizziness—Dexamethasone—hematologic cancer	2.34e-05	0.000121	CcSEcCtD
Amitriptyline—Hyperhidrosis—Epirubicin—hematologic cancer	2.33e-05	0.000121	CcSEcCtD
Amitriptyline—Insomnia—Methotrexate—hematologic cancer	2.33e-05	0.000121	CcSEcCtD
Amitriptyline—Anxiety—Doxorubicin—hematologic cancer	2.31e-05	0.00012	CcSEcCtD
Amitriptyline—Nausea—Triamcinolone—hematologic cancer	2.31e-05	0.00012	CcSEcCtD
Amitriptyline—Paraesthesia—Methotrexate—hematologic cancer	2.31e-05	0.00012	CcSEcCtD
Amitriptyline—Discomfort—Doxorubicin—hematologic cancer	2.29e-05	0.000119	CcSEcCtD
Amitriptyline—Anorexia—Epirubicin—hematologic cancer	2.29e-05	0.000119	CcSEcCtD
Amitriptyline—Somnolence—Methotrexate—hematologic cancer	2.29e-05	0.000119	CcSEcCtD
Amitriptyline—Dry mouth—Doxorubicin—hematologic cancer	2.27e-05	0.000118	CcSEcCtD
Amitriptyline—Dyspepsia—Methotrexate—hematologic cancer	2.26e-05	0.000117	CcSEcCtD
Amitriptyline—Hypotension—Epirubicin—hematologic cancer	2.25e-05	0.000117	CcSEcCtD
Amitriptyline—Vomiting—Dexamethasone—hematologic cancer	2.25e-05	0.000116	CcSEcCtD
Amitriptyline—Vomiting—Betamethasone—hematologic cancer	2.25e-05	0.000116	CcSEcCtD
Amitriptyline—Confusional state—Doxorubicin—hematologic cancer	2.24e-05	0.000116	CcSEcCtD
Amitriptyline—Decreased appetite—Methotrexate—hematologic cancer	2.24e-05	0.000116	CcSEcCtD
Amitriptyline—Rash—Betamethasone—hematologic cancer	2.23e-05	0.000115	CcSEcCtD
Amitriptyline—Rash—Dexamethasone—hematologic cancer	2.23e-05	0.000115	CcSEcCtD
Amitriptyline—Oedema—Doxorubicin—hematologic cancer	2.23e-05	0.000115	CcSEcCtD
Amitriptyline—Dermatitis—Betamethasone—hematologic cancer	2.23e-05	0.000115	CcSEcCtD
Amitriptyline—Dermatitis—Dexamethasone—hematologic cancer	2.23e-05	0.000115	CcSEcCtD
Amitriptyline—Fatigue—Methotrexate—hematologic cancer	2.22e-05	0.000115	CcSEcCtD
Amitriptyline—Headache—Dexamethasone—hematologic cancer	2.21e-05	0.000115	CcSEcCtD
Amitriptyline—Headache—Betamethasone—hematologic cancer	2.21e-05	0.000115	CcSEcCtD
Amitriptyline—Asthenia—Prednisone—hematologic cancer	2.21e-05	0.000114	CcSEcCtD
Amitriptyline—Shock—Doxorubicin—hematologic cancer	2.19e-05	0.000114	CcSEcCtD
Amitriptyline—Thrombocytopenia—Doxorubicin—hematologic cancer	2.18e-05	0.000113	CcSEcCtD
Amitriptyline—Imipramine—ABCB1—hematologic cancer	2.18e-05	0.0231	CrCbGaD
Amitriptyline—Pruritus—Prednisone—hematologic cancer	2.18e-05	0.000113	CcSEcCtD
Amitriptyline—Insomnia—Epirubicin—hematologic cancer	2.18e-05	0.000113	CcSEcCtD
Amitriptyline—Tachycardia—Doxorubicin—hematologic cancer	2.17e-05	0.000113	CcSEcCtD
Amitriptyline—Paraesthesia—Epirubicin—hematologic cancer	2.16e-05	0.000112	CcSEcCtD
Amitriptyline—Hyperhidrosis—Doxorubicin—hematologic cancer	2.15e-05	0.000112	CcSEcCtD
Amitriptyline—Somnolence—Epirubicin—hematologic cancer	2.14e-05	0.000111	CcSEcCtD
Amitriptyline—Anorexia—Doxorubicin—hematologic cancer	2.12e-05	0.00011	CcSEcCtD
Amitriptyline—Feeling abnormal—Methotrexate—hematologic cancer	2.12e-05	0.00011	CcSEcCtD
Amitriptyline—Dyspepsia—Epirubicin—hematologic cancer	2.12e-05	0.00011	CcSEcCtD
Amitriptyline—Diarrhoea—Prednisone—hematologic cancer	2.11e-05	0.000109	CcSEcCtD
Amitriptyline—Nausea—Betamethasone—hematologic cancer	2.1e-05	0.000109	CcSEcCtD
Amitriptyline—Nausea—Dexamethasone—hematologic cancer	2.1e-05	0.000109	CcSEcCtD
Amitriptyline—Decreased appetite—Epirubicin—hematologic cancer	2.09e-05	0.000108	CcSEcCtD
Amitriptyline—Hypotension—Doxorubicin—hematologic cancer	2.08e-05	0.000108	CcSEcCtD
Amitriptyline—Fatigue—Epirubicin—hematologic cancer	2.07e-05	0.000108	CcSEcCtD
Amitriptyline—Constipation—Epirubicin—hematologic cancer	2.06e-05	0.000107	CcSEcCtD
Amitriptyline—Urticaria—Methotrexate—hematologic cancer	2.04e-05	0.000106	CcSEcCtD
Amitriptyline—Dizziness—Prednisone—hematologic cancer	2.03e-05	0.000105	CcSEcCtD
Amitriptyline—Body temperature increased—Methotrexate—hematologic cancer	2.03e-05	0.000105	CcSEcCtD
Amitriptyline—Insomnia—Doxorubicin—hematologic cancer	2.01e-05	0.000104	CcSEcCtD
Amitriptyline—Paraesthesia—Doxorubicin—hematologic cancer	2e-05	0.000104	CcSEcCtD
Amitriptyline—Feeling abnormal—Epirubicin—hematologic cancer	1.98e-05	0.000103	CcSEcCtD
Amitriptyline—Somnolence—Doxorubicin—hematologic cancer	1.98e-05	0.000103	CcSEcCtD
Amitriptyline—Dyspepsia—Doxorubicin—hematologic cancer	1.96e-05	0.000102	CcSEcCtD
Amitriptyline—Vomiting—Prednisone—hematologic cancer	1.96e-05	0.000101	CcSEcCtD
Amitriptyline—Rash—Prednisone—hematologic cancer	1.94e-05	0.000101	CcSEcCtD
Amitriptyline—Dermatitis—Prednisone—hematologic cancer	1.94e-05	0.0001	CcSEcCtD
Amitriptyline—Decreased appetite—Doxorubicin—hematologic cancer	1.94e-05	0.0001	CcSEcCtD
Amitriptyline—Headache—Prednisone—hematologic cancer	1.93e-05	9.99e-05	CcSEcCtD
Amitriptyline—Fatigue—Doxorubicin—hematologic cancer	1.92e-05	9.95e-05	CcSEcCtD
Amitriptyline—Urticaria—Epirubicin—hematologic cancer	1.91e-05	9.91e-05	CcSEcCtD
Amitriptyline—Constipation—Doxorubicin—hematologic cancer	1.9e-05	9.87e-05	CcSEcCtD
Amitriptyline—Body temperature increased—Epirubicin—hematologic cancer	1.9e-05	9.86e-05	CcSEcCtD
Amitriptyline—Asthenia—Methotrexate—hematologic cancer	1.84e-05	9.56e-05	CcSEcCtD
Amitriptyline—Feeling abnormal—Doxorubicin—hematologic cancer	1.83e-05	9.51e-05	CcSEcCtD
Amitriptyline—Nausea—Prednisone—hematologic cancer	1.83e-05	9.47e-05	CcSEcCtD
Amitriptyline—Pruritus—Methotrexate—hematologic cancer	1.82e-05	9.43e-05	CcSEcCtD
Amitriptyline—Urticaria—Doxorubicin—hematologic cancer	1.77e-05	9.17e-05	CcSEcCtD
Amitriptyline—Body temperature increased—Doxorubicin—hematologic cancer	1.76e-05	9.12e-05	CcSEcCtD
Amitriptyline—Diarrhoea—Methotrexate—hematologic cancer	1.76e-05	9.12e-05	CcSEcCtD
Amitriptyline—Asthenia—Epirubicin—hematologic cancer	1.73e-05	8.95e-05	CcSEcCtD
Amitriptyline—Pruritus—Epirubicin—hematologic cancer	1.7e-05	8.83e-05	CcSEcCtD
Amitriptyline—Dizziness—Methotrexate—hematologic cancer	1.7e-05	8.81e-05	CcSEcCtD
Amitriptyline—Diarrhoea—Epirubicin—hematologic cancer	1.65e-05	8.54e-05	CcSEcCtD
Amitriptyline—Vomiting—Methotrexate—hematologic cancer	1.63e-05	8.48e-05	CcSEcCtD
Amitriptyline—Rash—Methotrexate—hematologic cancer	1.62e-05	8.4e-05	CcSEcCtD
Amitriptyline—Dermatitis—Methotrexate—hematologic cancer	1.62e-05	8.4e-05	CcSEcCtD
Amitriptyline—Headache—Methotrexate—hematologic cancer	1.61e-05	8.35e-05	CcSEcCtD
Amitriptyline—Asthenia—Doxorubicin—hematologic cancer	1.6e-05	8.28e-05	CcSEcCtD
Amitriptyline—Dizziness—Epirubicin—hematologic cancer	1.59e-05	8.25e-05	CcSEcCtD
Amitriptyline—Pruritus—Doxorubicin—hematologic cancer	1.58e-05	8.17e-05	CcSEcCtD
Amitriptyline—Vomiting—Epirubicin—hematologic cancer	1.53e-05	7.93e-05	CcSEcCtD
Amitriptyline—Nausea—Methotrexate—hematologic cancer	1.53e-05	7.92e-05	CcSEcCtD
Amitriptyline—Diarrhoea—Doxorubicin—hematologic cancer	1.52e-05	7.9e-05	CcSEcCtD
Amitriptyline—Rash—Epirubicin—hematologic cancer	1.52e-05	7.87e-05	CcSEcCtD
Amitriptyline—Dermatitis—Epirubicin—hematologic cancer	1.52e-05	7.86e-05	CcSEcCtD
Amitriptyline—Headache—Epirubicin—hematologic cancer	1.51e-05	7.81e-05	CcSEcCtD
Amitriptyline—Dizziness—Doxorubicin—hematologic cancer	1.47e-05	7.63e-05	CcSEcCtD
Amitriptyline—Nausea—Epirubicin—hematologic cancer	1.43e-05	7.41e-05	CcSEcCtD
Amitriptyline—Vomiting—Doxorubicin—hematologic cancer	1.42e-05	7.34e-05	CcSEcCtD
Amitriptyline—Rash—Doxorubicin—hematologic cancer	1.4e-05	7.28e-05	CcSEcCtD
Amitriptyline—Dermatitis—Doxorubicin—hematologic cancer	1.4e-05	7.27e-05	CcSEcCtD
Amitriptyline—Headache—Doxorubicin—hematologic cancer	1.39e-05	7.23e-05	CcSEcCtD
Amitriptyline—Nausea—Doxorubicin—hematologic cancer	1.32e-05	6.86e-05	CcSEcCtD
Amitriptyline—ADRA2A—Signaling Pathways—CASP3—hematologic cancer	7.9e-07	6e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—AKT1—hematologic cancer	7.89e-07	6e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IL2—hematologic cancer	7.89e-07	5.99e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PIK3R1—hematologic cancer	7.89e-07	5.99e-06	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—TP53—hematologic cancer	7.87e-07	5.98e-06	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—HRAS—hematologic cancer	7.86e-07	5.97e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—IL6—hematologic cancer	7.85e-07	5.96e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MYC—hematologic cancer	7.85e-07	5.96e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	7.84e-07	5.95e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	7.83e-07	5.95e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	7.82e-07	5.94e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MAPK8—hematologic cancer	7.82e-07	5.94e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MYC—hematologic cancer	7.81e-07	5.93e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—AKT1—hematologic cancer	7.79e-07	5.92e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TGFB1—hematologic cancer	7.79e-07	5.92e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—EP300—hematologic cancer	7.78e-07	5.91e-06	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—EP300—hematologic cancer	7.77e-07	5.91e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—EP300—hematologic cancer	7.76e-07	5.9e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	7.76e-07	5.9e-06	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—EP300—hematologic cancer	7.76e-07	5.89e-06	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—IL6—hematologic cancer	7.74e-07	5.88e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—EP300—hematologic cancer	7.74e-07	5.88e-06	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—PIK3CA—hematologic cancer	7.72e-07	5.87e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—EP300—hematologic cancer	7.71e-07	5.86e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PIK3R1—hematologic cancer	7.7e-07	5.85e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GSTM1—hematologic cancer	7.69e-07	5.85e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—NCOR1—hematologic cancer	7.69e-07	5.85e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CCND1—hematologic cancer	7.69e-07	5.84e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—SRC—hematologic cancer	7.69e-07	5.84e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MAPK3—hematologic cancer	7.69e-07	5.84e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CD—hematologic cancer	7.68e-07	5.84e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—JUN—hematologic cancer	7.67e-07	5.83e-06	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—PIK3CA—hematologic cancer	7.64e-07	5.81e-06	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—PIK3CA—hematologic cancer	7.64e-07	5.81e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—EP300—hematologic cancer	7.64e-07	5.81e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—EP300—hematologic cancer	7.62e-07	5.79e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CD—hematologic cancer	7.61e-07	5.79e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—ALB—hematologic cancer	7.58e-07	5.76e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—SRC—hematologic cancer	7.57e-07	5.75e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—SRC—hematologic cancer	7.55e-07	5.74e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—SRC—hematologic cancer	7.53e-07	5.72e-06	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—HRAS—hematologic cancer	7.52e-07	5.72e-06	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—IL6—hematologic cancer	7.52e-07	5.71e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—ALB—hematologic cancer	7.52e-07	5.71e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—SRC—hematologic cancer	7.5e-07	5.7e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—VEGFA—hematologic cancer	7.49e-07	5.69e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MYC—hematologic cancer	7.47e-07	5.68e-06	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—TP53—hematologic cancer	7.47e-07	5.67e-06	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—AKT1—hematologic cancer	7.46e-07	5.67e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TGFB1—hematologic cancer	7.46e-07	5.67e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CDKN1A—hematologic cancer	7.44e-07	5.65e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—SRC—hematologic cancer	7.43e-07	5.65e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PTEN—hematologic cancer	7.42e-07	5.64e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—STAT3—hematologic cancer	7.42e-07	5.63e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—SRC—hematologic cancer	7.41e-07	5.63e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CG—hematologic cancer	7.4e-07	5.62e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—NRAS—hematologic cancer	7.4e-07	5.62e-06	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—TP53—hematologic cancer	7.4e-07	5.62e-06	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—TP53—hematologic cancer	7.4e-07	5.62e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	7.37e-07	5.6e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—VEGFA—hematologic cancer	7.35e-07	5.59e-06	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—AKT1—hematologic cancer	7.35e-07	5.59e-06	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—AKT1—hematologic cancer	7.34e-07	5.58e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—VEGFA—hematologic cancer	7.33e-07	5.57e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—VEGFA—hematologic cancer	7.31e-07	5.55e-06	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—AKT1—hematologic cancer	7.3e-07	5.54e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—STAT3—hematologic cancer	7.3e-07	5.54e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—STAT3—hematologic cancer	7.28e-07	5.53e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—NRAS—hematologic cancer	7.28e-07	5.53e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PIK3CB—hematologic cancer	7.28e-07	5.53e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—NRAS—hematologic cancer	7.26e-07	5.52e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MAPK8—hematologic cancer	7.26e-07	5.52e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—STAT3—hematologic cancer	7.26e-07	5.51e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3R1—hematologic cancer	7.25e-07	5.51e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—KRAS—hematologic cancer	7.25e-07	5.51e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—AKT1—hematologic cancer	7.24e-07	5.5e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—NRAS—hematologic cancer	7.24e-07	5.5e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	7.24e-07	5.5e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—STAT3—hematologic cancer	7.23e-07	5.5e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—NRAS—hematologic cancer	7.22e-07	5.48e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—VEGFA—hematologic cancer	7.22e-07	5.48e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—KRAS—hematologic cancer	7.21e-07	5.48e-06	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—IL6—hematologic cancer	7.2e-07	5.47e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3R1—hematologic cancer	7.19e-07	5.46e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—STAT3—hematologic cancer	7.16e-07	5.44e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—NRAS—hematologic cancer	7.15e-07	5.43e-06	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—AKT1—hematologic cancer	7.15e-07	5.43e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—STAT3—hematologic cancer	7.15e-07	5.43e-06	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—HRAS—hematologic cancer	7.14e-07	5.43e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—NRAS—hematologic cancer	7.13e-07	5.42e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PIK3CB—hematologic cancer	7.1e-07	5.4e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MAPK3—hematologic cancer	7.09e-07	5.38e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—EP300—hematologic cancer	7.08e-07	5.38e-06	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—HRAS—hematologic cancer	7.07e-07	5.37e-06	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—HRAS—hematologic cancer	7.07e-07	5.37e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PTEN—hematologic cancer	7.05e-07	5.35e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PTEN—hematologic cancer	7.01e-07	5.32e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	6.97e-07	5.3e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MAPK3—hematologic cancer	6.96e-07	5.29e-06	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—AKT1—hematologic cancer	6.94e-07	5.27e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MAPK3—hematologic cancer	6.93e-07	5.27e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MAPK3—hematologic cancer	6.91e-07	5.25e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—KRAS—hematologic cancer	6.91e-07	5.25e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MYC—hematologic cancer	6.89e-07	5.24e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—SRC—hematologic cancer	6.88e-07	5.23e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TGFB1—hematologic cancer	6.87e-07	5.22e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CREBBP—hematologic cancer	6.86e-07	5.21e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	6.84e-07	5.2e-06	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—IL6—hematologic cancer	6.84e-07	5.19e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MAPK3—hematologic cancer	6.83e-07	5.19e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—PIK3CA—hematologic cancer	6.83e-07	5.19e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—MTHFR—hematologic cancer	6.8e-07	5.17e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MYC—hematologic cancer	6.78e-07	5.15e-06	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—IL6—hematologic cancer	6.77e-07	5.14e-06	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—IL6—hematologic cancer	6.77e-07	5.14e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MYC—hematologic cancer	6.77e-07	5.14e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	6.76e-07	5.14e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TGFB1—hematologic cancer	6.75e-07	5.13e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MYC—hematologic cancer	6.74e-07	5.12e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TGFB1—hematologic cancer	6.73e-07	5.11e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MYC—hematologic cancer	6.72e-07	5.11e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—EP300—hematologic cancer	6.72e-07	5.11e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TGFB1—hematologic cancer	6.71e-07	5.1e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—VEGFA—hematologic cancer	6.7e-07	5.09e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CB—hematologic cancer	6.69e-07	5.09e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—EP300—hematologic cancer	6.68e-07	5.08e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	6.66e-07	5.06e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MYC—hematologic cancer	6.66e-07	5.06e-06	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—AKT1—hematologic cancer	6.64e-07	5.05e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	6.64e-07	5.05e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MYC—hematologic cancer	6.64e-07	5.04e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—STAT3—hematologic cancer	6.64e-07	5.04e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CB—hematologic cancer	6.64e-07	5.04e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—PIK3CA—hematologic cancer	6.63e-07	5.04e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TGFB1—hematologic cancer	6.62e-07	5.03e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—NRAS—hematologic cancer	6.62e-07	5.03e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CD—hematologic cancer	6.51e-07	4.94e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TP53—hematologic cancer	6.45e-07	4.9e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—ALB—hematologic cancer	6.42e-07	4.88e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TP53—hematologic cancer	6.41e-07	4.87e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—KRAS—hematologic cancer	6.37e-07	4.84e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—PIK3CA—hematologic cancer	6.35e-07	4.82e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MAPK3—hematologic cancer	6.34e-07	4.82e-06	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—AKT1—hematologic cancer	6.31e-07	4.79e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTEN—hematologic cancer	6.29e-07	4.78e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—KRAS—hematologic cancer	6.27e-07	4.76e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—PIK3CA—hematologic cancer	6.26e-07	4.76e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—KRAS—hematologic cancer	6.25e-07	4.75e-06	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—AKT1—hematologic cancer	6.25e-07	4.75e-06	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—AKT1—hematologic cancer	6.25e-07	4.75e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—KRAS—hematologic cancer	6.23e-07	4.74e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—KRAS—hematologic cancer	6.21e-07	4.72e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MYC—hematologic cancer	6.17e-07	4.69e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—HRAS—hematologic cancer	6.16e-07	4.68e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TGFB1—hematologic cancer	6.15e-07	4.68e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—KRAS—hematologic cancer	6.15e-07	4.67e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3R1—hematologic cancer	6.14e-07	4.67e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTEN—hematologic cancer	6.14e-07	4.66e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TP53—hematologic cancer	6.14e-07	4.66e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—KRAS—hematologic cancer	6.13e-07	4.66e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—HRAS—hematologic cancer	6.13e-07	4.66e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—EP300—hematologic cancer	6e-07	4.56e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—IL6—hematologic cancer	5.9e-07	4.48e-06	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PIK3CA—hematologic cancer	5.87e-07	4.46e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—HRAS—hematologic cancer	5.87e-07	4.46e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—IL6—hematologic cancer	5.87e-07	4.46e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—EP300—hematologic cancer	5.85e-07	4.45e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	5.85e-07	4.44e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTEN—hematologic cancer	5.78e-07	4.4e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	5.76e-07	4.37e-06	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PIK3CA—hematologic cancer	5.75e-07	4.37e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	5.74e-07	4.36e-06	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PIK3CA—hematologic cancer	5.74e-07	4.36e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTEN—hematologic cancer	5.73e-07	4.36e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—PIK3CA—hematologic cancer	5.73e-07	4.35e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CG—hematologic cancer	5.71e-07	4.34e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—PIK3CA—hematologic cancer	5.71e-07	4.34e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—KRAS—hematologic cancer	5.7e-07	4.33e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CB—hematologic cancer	5.67e-07	4.31e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TP53—hematologic cancer	5.66e-07	4.3e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	5.65e-07	4.29e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—PIK3CA—hematologic cancer	5.64e-07	4.28e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IL6—hematologic cancer	5.62e-07	4.27e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—AKT1—hematologic cancer	5.58e-07	4.24e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TP53—hematologic cancer	5.57e-07	4.23e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TP53—hematologic cancer	5.56e-07	4.22e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TP53—hematologic cancer	5.54e-07	4.21e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TP53—hematologic cancer	5.52e-07	4.2e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—EP300—hematologic cancer	5.52e-07	4.19e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—EP300—hematologic cancer	5.47e-07	4.16e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TP53—hematologic cancer	5.47e-07	4.15e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TP53—hematologic cancer	5.45e-07	4.14e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—AKT1—hematologic cancer	5.44e-07	4.14e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—AKT1—hematologic cancer	5.41e-07	4.11e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—HRAS—hematologic cancer	5.41e-07	4.11e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—HRAS—hematologic cancer	5.33e-07	4.05e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—HRAS—hematologic cancer	5.31e-07	4.04e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—HRAS—hematologic cancer	5.3e-07	4.02e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CREBBP—hematologic cancer	5.3e-07	4.02e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—HRAS—hematologic cancer	5.28e-07	4.01e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PIK3CA—hematologic cancer	5.24e-07	3.98e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—HRAS—hematologic cancer	5.23e-07	3.97e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—HRAS—hematologic cancer	5.21e-07	3.96e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—AKT1—hematologic cancer	5.18e-07	3.94e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IL6—hematologic cancer	5.18e-07	3.94e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—AKT1—hematologic cancer	5.12e-07	3.89e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IL6—hematologic cancer	5.1e-07	3.87e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IL6—hematologic cancer	5.09e-07	3.86e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IL6—hematologic cancer	5.07e-07	3.85e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TP53—hematologic cancer	5.07e-07	3.85e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IL6—hematologic cancer	5.05e-07	3.84e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CD—hematologic cancer	5.02e-07	3.82e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IL6—hematologic cancer	5e-07	3.8e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IL6—hematologic cancer	4.99e-07	3.79e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PIK3CA—hematologic cancer	4.97e-07	3.78e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ALB—hematologic cancer	4.96e-07	3.77e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PIK3CA—hematologic cancer	4.94e-07	3.76e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTEN—hematologic cancer	4.9e-07	3.72e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—HRAS—hematologic cancer	4.84e-07	3.68e-06	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—AKT1—hematologic cancer	4.8e-07	3.64e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—AKT1—hematologic cancer	4.78e-07	3.63e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3R1—hematologic cancer	4.74e-07	3.6e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—AKT1—hematologic cancer	4.7e-07	3.57e-06	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—AKT1—hematologic cancer	4.7e-07	3.57e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—AKT1—hematologic cancer	4.69e-07	3.57e-06	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—AKT1—hematologic cancer	4.69e-07	3.56e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—AKT1—hematologic cancer	4.68e-07	3.55e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—EP300—hematologic cancer	4.67e-07	3.55e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—AKT1—hematologic cancer	4.66e-07	3.54e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IL6—hematologic cancer	4.64e-07	3.52e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—AKT1—hematologic cancer	4.62e-07	3.51e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—AKT1—hematologic cancer	4.6e-07	3.5e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PIK3CA—hematologic cancer	4.44e-07	3.37e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CB—hematologic cancer	4.38e-07	3.33e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PIK3CA—hematologic cancer	4.33e-07	3.29e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—AKT1—hematologic cancer	4.28e-07	3.25e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CA—hematologic cancer	4.08e-07	3.1e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—AKT1—hematologic cancer	4.06e-07	3.09e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CA—hematologic cancer	4.05e-07	3.07e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—AKT1—hematologic cancer	4.04e-07	3.07e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTEN—hematologic cancer	3.78e-07	2.87e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—AKT1—hematologic cancer	3.62e-07	2.75e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—EP300—hematologic cancer	3.61e-07	2.74e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—AKT1—hematologic cancer	3.54e-07	2.69e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CA—hematologic cancer	3.46e-07	2.63e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—AKT1—hematologic cancer	3.33e-07	2.53e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—AKT1—hematologic cancer	3.3e-07	2.51e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—AKT1—hematologic cancer	2.82e-07	2.15e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CA—hematologic cancer	2.67e-07	2.03e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—AKT1—hematologic cancer	2.18e-07	1.66e-06	CbGpPWpGaD
